NEUGEBOREN EDWARD has filed 3 insider transactions across 2 companies since April 2025.
Most recent transaction: a grant/award of 10000 shares of Grace Therapeutics, Inc. ($GRCE) on January 08, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2026 | Grace Therapeutics, Inc. | $GRCE | NEUGEBOREN EDWARD | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 16,933,620 | 9999.99% | 0.06% |
| May 9, 2025 | Grace Therapeutics, Inc. | $GRCE | NEUGEBOREN EDWARD | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 12,087,270 | 9999.99% | 0.08% |
| April 30, 2025 | Matinas BioPharma Holdings, Inc. | $MTNB | NEUGEBOREN EDWARD | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |